Entheon Biomedical Corp
Entheon Biomedical Corp. operates as a biotechnology research and development company. The company develops products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.
Market Cap & Net Worth: Entheon Biomedical Corp (ENTBF)
Entheon Biomedical Corp (OTCQB:ENTBF) has a market capitalization of $1.23 Million ($1.23 Million) as of March 18, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #36071 globally and #11733 in its home market, demonstrating a 3.85% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Entheon Biomedical Corp's stock price $0.09 by its total outstanding shares 13858934 (13.86 Million).
Entheon Biomedical Corp Market Cap History: 2020 to 2025
Entheon Biomedical Corp's market capitalization history from 2020 to 2025. Data shows growth from $100.63 Million to $1.23 Million (101.88% CAGR).
Entheon Biomedical Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Entheon Biomedical Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
5.54x
Entheon Biomedical Corp's market cap is 5.54 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $1.80 Million | $21.67K | -$8.89 Million | 83.14x | N/A |
| 2023 | $914.69K | $189.68K | -$8.52 Million | 4.82x | N/A |
| 2024 | $1.39 Million | $250.32K | -$300.00K | 5.54x | N/A |
Competitor Companies of ENTBF by Market Capitalization
Companies near Entheon Biomedical Corp in the global market cap rankings as of March 18, 2026.
Key companies related to Entheon Biomedical Corp by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Entheon Biomedical Corp Historical Marketcap From 2020 to 2025
Between 2020 and today, Entheon Biomedical Corp's market cap moved from $100.63 Million to $ 1.23 Million, with a yearly change of 101.88%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.23 Million | -11.00% |
| 2024 | $1.39 Million | +51.52% |
| 2023 | $914.69K | -49.23% |
| 2022 | $1.80 Million | -94.84% |
| 2021 | $34.92 Million | -65.29% |
| 2020 | $100.63 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Entheon Biomedical Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.23 Million USD |
| MoneyControl | $1.23 Million USD |
| MarketWatch | $1.23 Million USD |
| marketcap.company | $1.23 Million USD |
| Reuters | $1.23 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.